InvestorsHub Logo

Zooker

08/28/14 5:24 PM

#6433 RE: G Bert #6432

China knows that it's interest lies in buying the patents, especially if they can get them at wildly discounted prices! Then it has complete control, and the law biding nations will enforce its patents. PVCT can be picked up for a song right now, so why wouldn't China want to buy PV-10 outright (for about $10B or $50/Sh) knowing that the lifetime value, worldwide, is excess of about $500B, when the revenue from all indications is totaled! While Western Big Pharmas are too bloated and inept to strike quickly, the Dragon Pharma is not! SinoPharma is, IMHO, the odds on favorite right now!

http://www.businessweek.com/stories/2007-05-27/the-rush-to-test-drugs-in-china